Estimates Revisions GENFIT Deutsche Boerse AG
Stocks
XUP
FR0004163111
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
After hours 23:59:59 | |||
| 13.04 EUR | -3.26% |
|
13.55 | +3.91% |
| 07-03 | Genfit soars on news of U.S. reimbursement for a product |  |
| 07-03 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- GNFT Stock
- XUP Stock
- Consensus GENFIT
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
